Sangamo Therapeutics Inc. (SGMO)

15.95
0.00 (0.00)
NASDAQ : Health Technology
Prev Close 15.95
Open 15.70
Day Low/High 15.60 / 15.85
52 Wk Low/High 7.35 / 27.50
Volume 105.03K
Avg Volume 2.32M
Exchange NASDAQ
Shares Outstanding 101.50M
Market Cap 1.59B
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)
Indexes Are Holding Up Well, For Now

Indexes Are Holding Up Well, For Now

There are signs of stabilization, but the market is still digesting some very big swings.

Traders Need to Adapt to a New Reality

Traders Need to Adapt to a New Reality

The volatility trade that propped up markets is no longer available.

This Market Badly Needs a Rest

This Market Badly Needs a Rest

It would be a longer-term positive if the overbought conditions are alleviated.

In This Booming Stock Market, Think Like a Programmer Not a Critic

In This Booming Stock Market, Think Like a Programmer Not a Critic

What drives the trading action are structural issues, not macroeconomic news events or political drama.

How Trading Notes Can Increase Your Profits

How Trading Notes Can Increase Your Profits

Inertia is your biggest enemy in this market.

Selling Action Is Upon Us

Selling Action Is Upon Us

There is still a very strong appetite for individual stocks with momentum.

This Is a Great Market for Stock Traders

This Is a Great Market for Stock Traders

If you're looking for something negative to say about this action about the only thing you might argue is that the action is too positive.

First Week Of SGMO August 2018 Options Trading

First Week Of SGMO August 2018 Options Trading

Investors in Sangamo Therapeutics Inc saw new options become available this week, for the August 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Focused on Stock Picking Through This Volatility

Focused on Stock Picking Through This Volatility

I'm trying not to be sucked into the market-timing game and am looking mainly at setups in individual stocks.

The Return of Stock Market Volatility Can Create Stellar Opportunities

The Return of Stock Market Volatility Can Create Stellar Opportunities

But you need to be selective and have discipline.

SGMO Crosses Above Average Analyst Target

SGMO Crosses Above Average Analyst Target

In recent trading, shares of Sangamo Therapeutics Inc have crossed above the average analyst 12-month target price of $15.50, changing hands for $16.20/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Gains Elude Market as Momentum Withers

Gains Elude Market as Momentum Withers

Financial sector among the few bright spots.

How to Play This Cooling Momentum

How to Play This Cooling Momentum

We have shifted from a market that was mainly index driven by the FAANG names to one where stock picking is more important.

Delta Air Lines, BioTelemetry, TransUnion: 'Mad Money' Lightning Round

Delta Air Lines, BioTelemetry, TransUnion: 'Mad Money' Lightning Round

Jim Cramer is bullish on Delta Air Lines, BioTelemetry, TransUnion, Amgen and Littelfuse.

Are Stocks Cheaper Than We Think?: Cramer's 'Mad Money' Recap (Tues 10/17/17)

Are Stocks Cheaper Than We Think?: Cramer's 'Mad Money' Recap (Tues 10/17/17)

Jim Cramer says there's a case to be made for underpricing, even in this market.

Paratek Shares Higher on Microbiology Data -- Biotech Movers

Paratek Shares Higher on Microbiology Data -- Biotech Movers

The Boston firm said microbiology data show that investigational antibiotic omadacycline is 'active against the clinically important typical and atypical community-acquired bacterial pneumonia (CABP) pathogens.'

Entry Points Are Tough, and Post-Labor Day Action Is Historically Poor

Entry Points Are Tough, and Post-Labor Day Action Is Historically Poor

I've cut a few positions and haven't made any notable buys today.

Sangamo Therapeutics Reaches Analyst Target Price

Sangamo Therapeutics Reaches Analyst Target Price

In recent trading, shares of Sangamo Therapeutics Inc have crossed above the average analyst 12-month target price of $12.60, changing hands for $12.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Interesting SGMO Put And Call Options For February 2018

Interesting SGMO Put And Call Options For February 2018

Investors in Sangamo Therapeutics Inc saw new options begin trading this week, for the February 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 197 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

September 15th Options Now Available For Sangamo Therapeutics (SGMO)

September 15th Options Now Available For Sangamo Therapeutics (SGMO)

Investors in Sangamo Therapeutics Inc saw new options become available today, for the September 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGMO options chain for the new September 15th contracts and identified one put and one call contract of particular interest.

Steady Climb Amid Low Volume

Bulls should curb their enthusiasm.

Short Interest Drops 16% For SGMO

Short Interest Drops 16% For SGMO

The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 1,569,691 share decrease in total short interest for Sangamo Therapeutics Inc , to 8,230,673, a decrease of 16.02% since 06/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

We're Swimming in a Sea of Green This A.M.

We're Swimming in a Sea of Green This A.M.

There are few standout stocks, but there is broad strength so far today.

TheStreet Quant Rating: D (Sell)